論文・総説 - 新井　文子

1. Motomura, Y; Yoshifuji, K; Tachibana, T; Takase, H; Arai, A; Tanaka, K; Okada, K; Nogami, A; Umezawa, Y; Sakashita, C; Yamamoto, M; Mori, T; Nagao, T. Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma BRITISH JOURNAL OF HAEMATOLOGY. 2023.12; ( PubMed, DOI )

2. Hayato Tamai, Kenji Tajika, Kazutaka Nakayama, Ayako Arai. Treatment of relapsed aggressive adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation with mogamulizumab followed by lenalidomide. Bone Marrow Transplant. 2021.08; ( PubMed, DOI )

3. Manabu Matsunawa, Yasuyuki Inoue, Kunihiro Yagihashi, Yoshio Aida, Akiko Uchida, Yu Uemura, Yusuke Saiki, Madoka Takimoto, Fumiaki Sano, Ikuo Miura, Ayako Arai. The clinicopathological analysis of organising pneumonia in myelodysplastic syndrome: high frequency in der(1;7)(q10; p10). Br J Haematol. 2021.07; 194 (1): 214-217. ( PubMed, DOI )

4. Yusuke Saiki, Naoto Tomita, Akiko Uchida, Yu Uemura, Yoshinori Suzuki, Tsuneaki Hirakawa, Masayuki Kato, Masahiro Hoshikawa, Tsuyoshi Kawano, Naoya Nakamura, Ikuo Miura, Ayako Arai. Biopsy remains indispensable for evaluating bone marrow involvement in DLBCL patients despite the use of positron emission tomography. Int J Hematol. 2021.05; 113 (5): 675-681. ( PubMed, DOI )

5. Mayumi Yoshimori, Haruna Shibayama, Ken-Ichi Imadome, Fuyuko Kawano, Ayaka Ohashi, Miwako Nishio, Norio Shimizu, Morito Kurata, Shigeyoshi Fujiwara, Ayako Arai. Antineoplastic and anti-inflammatory effects of bortezomib on systemic chronic active EBV infection. Blood Adv. 2021.04; 5 (7): 1805-1815. ( PubMed, DOI )

6. Ayako Arai. Chronic Active Epstein-Barr Virus Infection: The Elucidation of the Pathophysiology and the Development of Therapeutic Methods. Microorganisms. 2021.01; 9 (1): ( PubMed, DOI )

7. Ichiro Yonese, Chizuko Sakashita, Ken-Ichi Imadome, Tohru Kobayashi, Masahide Yamamoto, Akihisa Sawada, Yoshinori Ito, Noriko Fukuhara, Asao Hirose, Yusuke Takeda, Masanori Makita, Tomoyuki Endo, Shun-Ichi Kimura, Masataka Ishimura, Osamu Miura, Shouichi Ohga, Hiroshi Kimura, Shigeyoshi Fujiwara, Ayako Arai. Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification. Blood Adv. 2020.07; 4 (13): 2918-2926. ( PubMed, DOI )

8. Misako Nagasaka, Makoto Yamagishi, Naoko Yagishita, Natsumi Araya, Seiichiro Kobayashi, Junya Makiyama, Miyuki Kubokawa, Junji Yamauchi, Daisuke Hasegawa, Ariella L G Coler-Reilly, Shuntaro Tsutsumi, Yu Uemura, Ayako Arai, Ayako Takata, Eisuke Inoue, Yasuhiro Hasegawa, Toshiki Watanabe, Yutaka Suzuki, Kaoru Uchimaru, Tomoo Sato, Yoshihisa Yamano. Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis. Proc Natl Acad Sci U S A. 2020.05; 117 (21): 11685-11691. ( PubMed, DOI )

9. Ayako Arai, Hiroshi Takase, Mayumi Yoshimori, Kouhei Yamamoto, Manabu Mochizuki, Osamu Miura. Gene expression profiling of primary vitreoretinal lymphoma. Cancer Sci. 2020.04; 111 (4): 1417-1421. ( PubMed, DOI )

10. Azuchi Masuda, Yasushi Isobe, Koichi Sugimoto, Mayumi Yoshimori, Ayako Arai, Norio Komatsu. Efficient recruitment of c-FLIP L to the death-inducing signaling complex leads to Fas resistance in natural killer-cell lymphoma. Cancer Sci. 2020.03; 111 (3): 807-816. ( PubMed, DOI )

11. Tomoka Ishida, Hiroshi Takase, Ayako Arai, Kyoko Ohno-Matsui. Multimodal imaging of secondary vitreoretinal lymphoma with optic neuritis and retinal vasculitis Am J Ophthalmol Case Rep. 2020; in press.

12. Takashi Nagaishi, Daiki Yamada, Kohei Suzuki, Ryosuke Fukuyo, Eiko Saito, Masayoshi Fukuda, Taro Watabe, Naoya Tsugawa, Kengo Takeuchi, Kouhei Yamamoto, Ayako Arai, Kazuo Ohtsuka, Mamoru Watanabe. Indolent T cell lymphoproliferative disorder with villous atrophy in small intestine diagnosed by single-balloon enteroscopy. Clin J Gastroenterol. 2019.10; 12 (5): 434-440. ( PubMed, DOI )

13. Hiroyuki Takahashi, Hiroshi Takase, Ayako Arai, Manabu Mochizuki, Kyoko Ohno-Matsui. Bilateral granulomatous panuveitis in two patients with T-cell type of chronic active Epstein-Barr virus infection. BMC Ophthalmol. 2019.03; 19 (1): 83. ( PubMed, DOI )

14. Arai A.. Advances in the Study of Chronic Active Epstein-Barr Virus Infection: Clinical Features Under the 2016 WHO Classification and Mechanisms of Development Frontiers Pediatrics. 2019.02;

15. Arai A.. Chronic active Epstein–Barr virus infection: a bi-faceted disease with inflammatory and neoplastic elements Immunological Medicine. 2019.01;

16. Yonese I, Takase H, Yoshimori M, Onozawa E, Tsuzura A, Miki T, Mochizuki M, Miura O, Arai A. CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential. European journal of haematology. 2018.11; ( PubMed, DOI )

17. Onozawa E, Shibayama H, Takada H, Imadome KI, Aoki S, Yoshimori M, Shimizu N, Fujiwara S, Koyama T, Miura O, Arai A. STAT3 is constitutively activated in chronic active Epstein-Barr virus infection and can be a therapeutic target. Oncotarget. 2018.07; 9 (57): 31077-31089. ( PubMed, DOI )

18. S Tokoro, T Namiki, K Miura, K Watanabe, A Arai, K Imadome, H Yokozeki. Chronic active Epstein-Barr virus infection with cutaneous lymphoproliferation: haemophagocytosis in the skin and haemophagocytic syndrome. J Eur Acad Dermatol Venereol. 2017.10; [Epub ahead of print] ( PubMed, DOI )

19. Akira Toriihara, Ayako Arai, Masashi Nakadate, Kouhei Yamamoto, Ken-Ichi Imadome, Osamu Miura, Ukihide Tateishi. FDG-PET/CT findings of chronic active Epstein-Barr virus infection. Leuk. Lymphoma. 2017.10; 1-4. ( PubMed, DOI )

20. Akira Toriihara, Reiko Nakajima, Ayako Arai, Masashi Nakadate, Koichiro Abe, Kazunori Kubota, Ukihide Tateishi. Pathogenesis and FDG-PET/CT findings of Epstein-Barr virus-related lymphoid neoplasms. Ann Nucl Med. 2017.07; 31 (6): 425-436. ( PubMed, DOI )